We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Liquid Chromatography Analyzer Evaluated for Hemoglobinopathy

By LabMedica International staff writers
Posted on 18 Jan 2017
Print article
Image: The ADAMS A1c, HA-8180 is a fully automated Glycohemoglobin (HbA1c) analyzer based on HPLC (Photo courtesy of Arkray).
Image: The ADAMS A1c, HA-8180 is a fully automated Glycohemoglobin (HbA1c) analyzer based on HPLC (Photo courtesy of Arkray).
The quantification of HbA2 and HbF, and the detection and quantification of hemoglobin variants, is an essential tool in the diagnosis of hemoglobinopathies such as thalassemia or sickle cell syndromes.

The narrow separation between normal and pathological HbA2 values, strict analytical quality of HbA2 measurement is an essential requirement for accurate diagnosis, particularly for genetic counseling when couples at-risk must be identified.

A hematologist at the Hospital Galdakao – Usansolo evaluated the analytical performance and quality of results obtained from a fully automated high-pressure liquid chromatography (HPLC) analyzer for routine estimation of HbA2 and the screening of β thalassemia. Blood specimens were obtained from patients whose diabetic control or hemoglobinopathy were being assessed.

The scientist measured HbA2 values with the fully automated Glycohemoglobin analyzer based on HPLC ADAMS A1c HA-8180 on Thalassemia mode and were compared with those obtained with their current method, the established HPLC ADAMSTM A1c HA-8160. Comparison was performed by running 400 samples from healthy subjects, 30 alpha and 80 beta carriers. Hemoglobin was measured on a XN counter. Different common variant hemoglobins were analyzed: HbS, HbC, HbD, HbJ, Hb Lepore, HbSC, Hb E, Hb O, and δβ thalassemia carriers with raised HbF. Twenty samples of heterozygous HbS were measured with capillary electrophoresis in the reference laboratory to discard the spurious increment of HbA2.

The mean difference between HbA2 results of ADAMS A1C HA-8180T and capillary electrophoresis, in samples of heterozygous HbS, was 0.2 %. The hematologist found an ample gap between healthy persons and carriers. A potential bias is that they have not included carriers of mutations producing borderline values of HbA2, which was absent in the area, and this fact must be considered in regions with high prevalence of those patients. The author concluded that the ADAMS A1c HA-8180T provided a rapid and reliable separation of HbA2. The measurement is accurate and reproducible, which is needed because of the slight difference between normal and pathological values. The gap in HbA2 values between normal subjects and β-thalassemia carriers makes this an appropriate method for rapid screening for carriers. The study was published in the December 2016 issue of the International Journal of Laboratory Hematology.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.